131 related articles for article (PubMed ID: 37926169)
1. RICH2 decreases the mitochondrial number and affects mitochondrial localization in diffuse low-grade glioma-related epilepsy.
Zhang J; Gong L; Zhu H; Sun W; Tian J; Zhang Y; Liu Q; Li X; Zhang F; Wang S; Zhu S; Ding D; Zhang W; Yang C
Neurobiol Dis; 2023 Nov; 188():106344. PubMed ID: 37926169
[TBL] [Abstract][Full Text] [Related]
2. Role of 1p/19q Codeletion in Diffuse Low-grade Glioma Tumour Prognosis.
Familiari P; Lapolla P; Picotti V; Palmieri M; Pesce A; Carosi G; Relucenti M; Nottola S; Gianno F; Minasi S; Antonelli M; Frati A; Santoro A; D'Andrea G; Bruzzaniti P; LA Pira B
Anticancer Res; 2023 Jun; 43(6):2659-2670. PubMed ID: 37247932
[TBL] [Abstract][Full Text] [Related]
3. Gene expression meta-analysis in diffuse low-grade glioma and the corresponding histological subtypes.
Wang S; Jin F; Fan W; Liu F; Zou Y; Hu X; Xu H; Han P
Sci Rep; 2017 Sep; 7(1):11741. PubMed ID: 28924174
[TBL] [Abstract][Full Text] [Related]
4. Cellular and molecular characterization of IDH1-mutated diffuse low grade gliomas reveals tumor heterogeneity and absence of EGFR/PDGFRα activation.
Azar S; Leventoux N; Ripoll C; Rigau V; Gozé C; Lorcy F; Bauchet L; Duffau H; Guichet PO; Rothhut B; Hugnot JP
Glia; 2018 Feb; 66(2):239-255. PubMed ID: 29027701
[TBL] [Abstract][Full Text] [Related]
5. Clinical Pearls and Advances in Molecular Researches of Epilepsy-Associated Tumors.
Phi JH; Kim SK
J Korean Neurosurg Soc; 2019 May; 62(3):313-320. PubMed ID: 31085957
[TBL] [Abstract][Full Text] [Related]
6. Diffuse Low-Grade Glioma-Related Epilepsy.
Pallud J; McKhann GM
Neurosurg Clin N Am; 2019 Jan; 30(1):43-54. PubMed ID: 30470404
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic algorithm for pathological evaluation of gliomas in a resource-constrained setting.
Jain S; Gupta P; Shankar KB; Singh R; Siraj F
J Cancer Res Ther; 2023; 19(3):562-566. PubMed ID: 37470575
[TBL] [Abstract][Full Text] [Related]
8. Diffuse low grade glioma and pregnancy: Practical considerations and clinical tips.
Somma T; Baiano C; Santi L; Sabatino G; Della Pepa GM; La Rocca G; Cappabianca P; Olivi A; Skrap M; Ius T
Clin Neurol Neurosurg; 2020 Nov; 198():106110. PubMed ID: 32818754
[TBL] [Abstract][Full Text] [Related]
9. Diffuse Low-Grade Glioma - Changing Concepts in Diagnosis and Management: A Review.
Jooma R; Waqas M; Khan I
Asian J Neurosurg; 2019; 14(2):356-363. PubMed ID: 31143247
[TBL] [Abstract][Full Text] [Related]
10. Resective surgery for patients with frontal lobe diffuse low-grade glioma-related epilepsy: predictors of seizure outcomes.
Zhang K; Liu D; Yang Z; Li X; Yang Z; He X
Ther Adv Chronic Dis; 2022; 13():20406223221141856. PubMed ID: 36545237
[TBL] [Abstract][Full Text] [Related]
11. Benign Glioma.
Wu PB; Filley AC; Miller ML; Bruce JN
Adv Exp Med Biol; 2023; 1405():31-71. PubMed ID: 37452934
[TBL] [Abstract][Full Text] [Related]
12. Expression Analyses of Rich2/Arhgap44, a Rho Family GTPase-Activating Protein, during Mouse Brain Development.
Goto N; Nishikawa M; Ito H; Noda M; Hamada N; Tabata H; Kinoshita M; Nagata KI
Dev Neurosci; 2023; 45(1):19-26. PubMed ID: 36630934
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of the 2016 WHO classification in Japanese patients with gliomas.
Iuchi T; Sugiyama T; Ohira M; Kageyama H; Yokoi S; Sakaida T; Hasegawa Y; Setoguchi T; Itami M
Brain Tumor Pathol; 2018 Apr; 35(2):71-80. PubMed ID: 29470683
[TBL] [Abstract][Full Text] [Related]
14. Delayed leptomeningeal and subependymal seeding after multiple surgeries for supratentorial diffuse low-grade gliomas in adults.
Alvarez de Eulate-Beramendi S; Rigau V; Taillandier L; Duffau H
J Neurosurg; 2014 Apr; 120(4):833-9. PubMed ID: 24286144
[TBL] [Abstract][Full Text] [Related]
15. Endocytosis-mediated mitochondrial transplantation: Transferring normal human astrocytic mitochondria into glioma cells rescues aerobic respiration and enhances radiosensitivity.
Sun C; Liu X; Wang B; Wang Z; Liu Y; Di C; Si J; Li H; Wu Q; Xu D; Li J; Li G; Wang Y; Wang F; Zhang H
Theranostics; 2019; 9(12):3595-3607. PubMed ID: 31281500
[TBL] [Abstract][Full Text] [Related]
16. National-level overall survival patterns for molecularly-defined diffuse glioma types in the United States.
Ostrom QT; Shoaf ML; Cioffi G; Waite K; Kruchko C; Wen PY; Brat DJ; Barnholtz-Sloan JS; Iorgulescu JB
Neuro Oncol; 2023 Apr; 25(4):799-807. PubMed ID: 35994777
[TBL] [Abstract][Full Text] [Related]
17. Rho-GTPase-activating protein interacting with Cdc-42-interacting protein 4 homolog 2 (Rich2): a new Ras-related C3 botulinum toxin substrate 1 (Rac1) GTPase-activating protein that controls dendritic spine morphogenesis.
Raynaud F; Moutin E; Schmidt S; Dahl J; Bertaso F; Boeckers TM; Homburger V; Fagni L
J Biol Chem; 2014 Jan; 289(5):2600-9. PubMed ID: 24352656
[TBL] [Abstract][Full Text] [Related]
18. Quantitative proteomic analysis shows differentially expressed HSPB1 in glioblastoma as a discriminating short from long survival factor and NOVA1 as a differentiation factor between low-grade astrocytoma and oligodendroglioma.
Gimenez M; Marie SK; Oba-Shinjo S; Uno M; Izumi C; Oliveira JB; Rosa JC
BMC Cancer; 2015 Jun; 15():481. PubMed ID: 26108672
[TBL] [Abstract][Full Text] [Related]
19. Systematic Review of Molecular Targeted Therapies for Adult-Type Diffuse Glioma: An Analysis of Clinical and Laboratory Studies.
Muzyka L; Goff NK; Choudhary N; Koltz MT
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445633
[TBL] [Abstract][Full Text] [Related]
20. Stemness and clinical features in relation to the subventricular zone in diffuse lower-grade glioma: an exploratory study.
Corell A; Gómez Vecchio T; Ferreyra Vega S; Dénes A; Neimantaite A; Hagerius A; Barchéus H; Solheim O; Lindskog C; Bontell TO; Carén H; Jakola AS; Smits A
Neurooncol Adv; 2022; 4(1):vdac074. PubMed ID: 35795469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]